Discovery of RNA's cataytic activity led to unexpected spin-offs, including a new scenario for the origin of life. In a different area, the ability of RNA catalysts (ribozymes) to cut an splice RNA molecules has sparked efforts to develop them as pharmaceuticals against viruses, cancer, and genetic diseases. Presented by Thomas Chech, Ph.D. Howard Hughes Medical Institute Holiday Lectures on Science 1995
Hide player controls
Hide resume playing